Effects of salivae miltiorrhizae liguspyragine hydrochloride and glucose injection the levels of main platelet thrombin receptors in chronic haemodialysis patients

Chinese Journal of Integrative Medicine

Volumn 17, Issue 8, 2011, Pages 625-630

  Li, Yan ^a   Shen, Lin ^a   Chen, Rui ^a   Li, Jing ^a   Lu, Fu Rong ^a   Qin, You ^a   Liu, Jan Guo ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Chronic haemodialysis; End stage renal disease; Platelet thrombin receptors; Salvia miltiorrhiza liguspyragine hydrochloride and glucose injection

Indexed keywords

HERBACEOUS AGENT; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 4; SALVIA MILTIORRHIZA LIGUSPYRAGINE HYDROCHLORIDE; UNCLASSIFIED DRUG; GLUCOSE; THROMBIN RECEPTOR;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HEMODIALYSIS PATIENT; HUMAN; INJECTION SITE PAIN; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RASH; RECEPTOR DOWN REGULATION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOSIS; TURBIDITY; CHEMISTRY; CLINICAL TRIAL; DRUG EFFECT; KIDNEY FUNCTION TEST; METABOLISM; MIDDLE AGED; RENAL REPLACEMENT THERAPY; SALVIA MILTIORRHIZA; THROMBOCYTE;

BLOOD PLATELETS; DRUGS, CHINESE HERBAL; FEMALE; GLUCOSE; HUMANS; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; PLATELET AGGREGATION; RECEPTORS, THROMBIN; RENAL DIALYSIS; SALVIA MILTIORRHIZA;

EID: 84855169987     PISSN: 16720415     EISSN: 19930402     Source Type: Journal    
DOI: 10.1007/s11655-011-0826-8     Document Type: Article

References (20)

1. Boccardo P, Remuzzi G, Galbusera M. Platelet dysfunction in renal failure. Semin Thromb Hemost 2004;30:579-589.
2. Li Y, Shen L, Chen R, Lu FR, Li J, Liu JG. Levels of main platelet thrombin receptors in older chronic haemodialysis patients. Chin Med J 2010;123:2495-2496.
3. Moal V, Brunet P, Dou L, Morange S, Sampol J, Berland Y. Impaired expression of glycoproteins on resting and stimulated platelets in uraemic patients. Nephrol Dial Transplant 2003;18:1834-1841.
4. Wang HY, eds. Nephropathy. 2nd ed. Beijing: People's Medical Publishing House; 1996:1385.
5. Rink TJ, Sage SO. Calcium signaling in human platelets. Annu Rev Physiol 1990;52:431-449.
6. Wyant TL, Smith PC, Brown B, Kantor AB. Whole blood microvolume laser scanning cytometry for monitoring resting and activated platelets. Platelets 2001;12:309-318.
7. Smith FB, Rumley A, Lee AJ, Leng GC, Fowkes FG, Lowe GD. Haemostatic factors and prediction of ischaemic heart disease and stroke in claudicants. Br J Haematol 1998;100:758-763.
8. Qin Y, Shen L, Lu FR, Shi W, Liu JG. Effect of Xiaoyu Zhixue Tablet on the expression of platelet membraneglycoprotein ?b/?/? complex in patients with chronic renal failure. Chin J Integr Med 2008;14:83-87.
9. Di Minno G, Cerbone A, Usberti M, Cianciaruso B, Cortese A, Farace MJ, et al. Platelet dysfunction in uremia. ?. Correction by arachidonic acid of the impaired exposure of fi brinogen receptors by adenosine diphosphate or collagen. J Lab Clin Med 1986;108:246-252.
10. Gralnick HR, McKeown LP, Williams SB, Shafer BC, Pierce L. Plasma and platelet von Willebrand factor defects in uremia. Am J Med 1988;85:806-810.
11. Zwaginga JJ, MJ IJ, de Groot PG, Vos J, de Bos Kuil RL, Sixma JJ. Defects in platelet adhesion and aggregate formation in uremic bleeding disorder can be attributed to factors in plasma. Arterioscler Thromb 1991;11:733-744.
12. Benigni A, Livio M, Dodesini P, Schieppati A, Panigada M, Mecca G, et al. Inhibition of human platelet aggregation by parathyroid hormone. Is cyclic AMP implicated? Am J Nephrol 1985;5:243-247.
13. Kyrle PA, Stockenhuber F, Brenner B, Gossinger H, Korninger C, Pabinger I, et al. Evidence for an increased generation of prostacyclin in the microvasculature and an impairment of the platelet alpha-granule release in chronic renal failure. Thromb Haemost 1988;60:205-208.
14. Covic L, Gresser AL, Kuliopulos A. Biphasic kinetics of activation and signaling for PAR1 and PAR4 thrombin receptors in platelets. Biochemistry 2000;39:5458-5467.
15. Shapiro MJ, Weiss EJ, Faruqi TR, Coughl SR. Protease-Activated receptors 1 and 4 are shut off with distinct kinetics after activation by thrombin. J Biol Chem 2000;275:25216-25221.
16. Diaz-Ricart M, Estebanell E, Cases A, Calls J, Lopez- Pedret J, Carretero M, et al. Abnormal platelet cytoskeletal assembly in hemodialyzed patients results in deficient tyrosine phosphorylation signaling. Kidney Int 2000;57:1905-1914.
17. Yang HX, Jiang HB. Clinical observation of combination of Danshen and Chuanxiongqin Injection and Astragali Injection in patients with stable angina pectoris. J Hunan Environ Biol Polytechnic (Chin) 2008;14(3):7-9.
18. Li S, Wan L. Experimental study on the preventive mechanism of Salviae Miltiorrhizae against atherosclerosis in rabbits models. J Huazhong Univ Sci Technol Med Sci 2004;24:233-235.
19. Wang Yan, Li Yan. Efficacy of Asparagine Hydrochloride and Glucose Injection on ischemic colitis. Chin J Gastroentero Hepatol (Chin) 2009;18: 646-648.
20. Che XW, Zhang Y, Wang H, Wang W. Effect of ligustrazine injection on levels of interleukin-4 and interferon-gamma in patients with bronchial asthma. Chin J Integr Med 2008;14:217-220.